Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Elliot, Charles A"'
Autor:
Rhodes, Christopher J, Wharton, John, Ghataorhe, Pavandeep, Watson, Geoffrey, Girerd, Barbara, Howard, Luke S, Gibbs, J Simon R, Condliffe, Robin, Elliot, Charles A, Kiely, David G, Simonneau, Gerald, Montani, David, Sitbon, Olivier, Gall, Henning, Schermuly, Ralph T, Ghofrani, H Ardeschir, Lawrie, Allan, Humbert, Marc, Wilkins, Martin R
Publikováno v:
In The Lancet Respiratory Medicine September 2017 5(9):717-726
Publikováno v:
Research in Social Sciences & Technology (RESSAT); 2023, Vol. 8 Issue 4, p345-359, 15p
Autor:
Reenika Aggarwal, Frances A. Shepherd, Penelope A. Bradbury, Adrian G. Sacher, Karmugi Balaratnam, Elliot Charles Smith, M. Catherine Brown, RuiQi Chen, Lawson Eng, Rouhi Fazelzad, Natasha B. Leighl, Katrina Hueniken, Shirley Xue Jiang, Jessica Weiss, Wei Xu, Sze Wah Samuel Chan, Geoffrey Liu
Publikováno v:
Clinical Lung Cancer. 22:390-407
Background Systemic inflammatory response (SIR) may influence prognosis in epidermal growth factor receptor (EGFR)-mutated (m) non–small-cell lung cancer (NSCLC). Pretreatment SIR markers (neutrophil-to-lymphocyte ratio [NLR], platelet-to-lymphocyt
Autor:
Spencer Soberano, Elliot Charles Smith, Frances A. Shepherd, Prodipto Pal, Malcolm Ryan, Penelope A. Bradbury, Lisa W. Le, Kate M. Mackay, Ming-Sound Tsao, Natasha B. Leighl, Sze Wah Chan, Adrian G. Sacher, Geoffrey Liu, Aline Fusco Fares, S. Lau
Publikováno v:
Clinical Lung Cancer. 22:253-259
Introduction The efficacy of immune checkpoint inhibitors (ICIs) is low among EGFR-mutated non–small-cell lung cancer (NSCLC), although prolonged responses have occasionally been reported. We investigated the association between mutation subtypes a
Autor:
Dongyang Yang, Jaime O. Claudio, Elliot Charles Smith, Aniket Bankar, Jose Mario Capo-Chichi, James A. Kennedy, Caroline J McNamara, Hassan Sibai, Hubert Tsui, Nancy Siddiq, Shabbir M.H. Alibhai, Verna Cheung, Dawn Maze, Vikas Gupta, Sarah Malik, Wei Xu, Andrea Arruda
Publikováno v:
British Journal of Haematology
Summary There is limited understanding of the impact of frailty on clinical outcomes in patients with myelofibrosis (MF). In this retrospective cohort study on 439 chronic phase MF patients [mean age: 68·7 ± 12 years; median follow‐up: 3·4 years
Autor:
Pryangka Rao, Shayan Kassirian, Jacqueline L. Bender, Arielle Geist, M. Catherine Brown, Karmugi Balaratnam, Katrina Hueniken, Geoffrey Liu, Lawson Eng, Ilana Geist, Chelsea Paulo, Abha A. Gupta, Elliot Charles Smith, Wei Xu, Alexander Magony, Mindy Liang
Publikováno v:
Supportive Care in Cancer. 29:5273-5281
Cancer patients may turn to social media (SM) to cope with distress. We investigated associations between distress and internet/SM use for cancer information/support. Adult patients at a Canadian cancer centre completed a cross-sectional survey on so
Autor:
Condliffe, Robin, Pickworth, Josephine A., Hopkinson, Kay, Walker, Sara J., Hameed, Abdul G., Suntharaligam, Jay, Soon, Elaine, Treacy, Carmen, Pepke-Zaba, Joanna, Francis, Sheila E., Crossman, David C., Newman, Christopher M. H., Elliot, Charles A., Morton, Allison C., Morrell, Nicholas W., Kiely, David G., Lawrie, Allan
Publikováno v:
Pulmonary Circulation, 2012 Jan 01. 2(1), 21-27.
Externí odkaz:
https://www.jstor.org/stable/10.4103/2045-8932.94819
Autor:
Reenika Aggarwal, Wei Xu, Mindy Liang, Elliot Charles Smith, Jackie Bender, Abha A. Gupta, Dongyang Yang, Ilana Geist, Geoffrey Liu, Lawson Eng, Shabbir M.H. Alibhai, Alexander Magony, Shayan Kassirian, Katrina Hueniken, Chelsea Paulo, Karmugi Balaratnam, M. Catherine Brown, Samir C. Grover, Jennifer M. Jones, Laura Mitchell
Publikováno v:
Journal of Geriatric Oncology. 11:1011-1019
The internet and social media provide information and support to cancer survivors, and adolescent and young adults (AYA, age 40 years), adults, and older (age 65+ years) cancer survivors may have different needs. We evaluated the impact of age on can
Publikováno v:
International Journal of Medical Students, Vol 8, Iss 1, Pp 26-32 (2020)
Lung cancer is one of the deadliest cancers in the world. Current clinical trials are focused on developing the next generation of therapies that target novel anti-cancer mechanisms. One approach is to prime the immune system, as the cancer has been
Autor:
Noah Stern, Elliot Charles Smith, Khurram M. Siddiqui, Shiva M. Nair, Malcolm Dewar, Madeleine Moussa, Jose A. Gomez, Joseph L. Chin
Publikováno v:
Scandinavian Journal of Urology. 54:215-219
Introduction: MRI-guided transurethral ultrasound ablation (TULSA) is a novel modality for minimally invasive ablation in patients with localised prostate cancer (PCa). A multi-national Phase 1 (30...